These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12036269)

  • 1. A piecewise-homogeneous Markov chain process of lung transplantation.
    Sharples LD; Taylor GI; Faddy M
    J Epidemiol Biostat; 2001; 6(4):349-55. PubMed ID: 12036269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients.
    Jackson CH; Sharples LD
    Stat Med; 2002 Jan; 21(1):113-28. PubMed ID: 11782054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-Markov models with phase-type sojourn distributions.
    Titman AC; Sharples LD
    Biometrics; 2010 Sep; 66(3):742-52. PubMed ID: 19912172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous time Markov chain approaches for analyzing transtheoretical models of health behavioral change: A case study and comparison of model estimations.
    Ma J; Chan W; Tilley BC
    Stat Methods Med Res; 2018 Feb; 27(2):593-607. PubMed ID: 27048681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. tdc.msm: an R library for the analysis of multi-state survival data.
    Meira-Machado L; Cadarso-Suárez C; de Uña-Alvarez J
    Comput Methods Programs Biomed; 2007 May; 86(2):131-40. PubMed ID: 17350136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitting and interpreting continuous-time latent Markov models for panel data.
    Lange JM; Minin VN
    Stat Med; 2013 Nov; 32(26):4581-95. PubMed ID: 23740756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for analyzing the cost of the main clinical events after lung transplantation.
    Sharples LD; Taylor GJ; Karnon J; Caine N; Buxton M; McNeil K; Wallwork J
    J Heart Lung Transplant; 2001 Apr; 20(4):474-82. PubMed ID: 11295586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation.
    van Rosmalen J; Toy M; O'Mahony JF
    Med Decis Making; 2013 Aug; 33(6):767-79. PubMed ID: 23715464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-Markov Arnason-Schwarz models.
    King R; Langrock R
    Biometrics; 2016 Jun; 72(2):619-28. PubMed ID: 26584064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous-Time Semi-Markov Models in Health Economic Decision Making: An Illustrative Example in Heart Failure Disease Management.
    Cao Q; Buskens E; Feenstra T; Jaarsma T; Hillege H; Postmus D
    Med Decis Making; 2016 Jan; 36(1):59-71. PubMed ID: 26174352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling nonhomogeneous Markov processes via time transformation.
    Hubbard RA; Inoue LYT; Fann JR
    Biometrics; 2008 Sep; 64(3):843-850. PubMed ID: 18047532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAS macro program for non-homogeneous Markov process in modeling multi-state disease progression.
    Hui-Min W; Ming-Fang Y; Chen TH
    Comput Methods Programs Biomed; 2004 Aug; 75(2):95-105. PubMed ID: 15212852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markov models in medical decision making: a practical guide.
    Sonnenberg FA; Beck JR
    Med Decis Making; 1993; 13(4):322-38. PubMed ID: 8246705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MKVPCI: a computer program for Markov models with piecewise constant intensities and covariates.
    Alioum A; Commenges D
    Comput Methods Programs Biomed; 2001 Feb; 64(2):109-119. PubMed ID: 11137193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flexible semi-Markov model for interval-censored data and goodness-of-fit testing.
    Foucher Y; Giral M; Soulillou JP; Daures JP
    Stat Methods Med Res; 2010 Apr; 19(2):127-45. PubMed ID: 18765502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A continuous time version and a generalization of a Markov-recapture model for trapping experiments.
    Alpizar-Jara R; Smith CE
    Math Biosci; 2008; 214(1-2):11-9. PubMed ID: 18556026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A piecewise Markov process for analysing survival from breast cancer in different risk groups.
    Pérez-Ocón R; Ruiz-Castro JE; Gámiz-Pérez ML
    Stat Med; 2001 Jan; 20(1):109-122. PubMed ID: 11135351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data.
    Du X; Li M; Zhu P; Wang J; Hou L; Li J; Meng H; Zhou M; Zhu C
    PLoS One; 2018; 13(8):e0200807. PubMed ID: 30133454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Markov process modelling to health status switching behaviour of infants.
    Biritwum RB; Odoom SI
    Int J Epidemiol; 1995 Feb; 24(1):177-82. PubMed ID: 7797340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MARKOV: a computer program for multi-state Markov models with covariables.
    Marshall G; Guo W; Jones RH
    Comput Methods Programs Biomed; 1995 Jul; 47(2):147-56. PubMed ID: 7587161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.